Reaction
Vascular Purpura reporting signals
As of the last recalculation, Vascular Purpura appears in 1,373 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is RIFAMPIN (PRR 52.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rifampin | 49 | 52.7 | 52.9 |
| Ketoprofen | 27 | 31.8 | 31.9 |
| Amoxicillin And Clavulanate Potassium | 53 | 30.7 | 30.8 |
| Nebivolol | 30 | 29.2 | 29.2 |
| Levofloxacin | 104 | 28.2 | 28.3 |
| Levofloxacin In 5% Dextrose | 104 | 28.2 | 28.3 |
| Cefazolin Sodium | 18 | 22.9 | 23.0 |
| Enoxaparin Sodium | 73 | 20.3 | 20.3 |
| Candesartan Cilexetil | 32 | 18.9 | 18.9 |
| Rifampicin | 12 | 18.1 | 18.2 |
| Cefazolin | 10 | 16.7 | 16.7 |
| Colchicine | 27 | 15.8 | 15.8 |
| Daptomycin | 9 | 14.9 | 14.9 |
| Piperacillin Sodium,Tazobactam Sodium | 24 | 13.9 | 14.0 |
| Nebivolol Hydrochloride | 30 | 13.8 | 13.8 |
| Umeclidinium | 8 | 13.6 | 13.6 |
| Telmisartan | 15 | 12.9 | 12.9 |
| Posaconazole Delayed-Release | 9 | 12.5 | 12.5 |
| Salmeterol Xinafoate | 7 | 12.4 | 12.4 |
| Tamsulosin Hydrochloride | 16 | 12.0 | 12.0 |
| Eplerenone | 10 | 11.9 | 11.9 |
| Dorzolamide Hydrochloride And Timolol Maleate | 6 | 11.6 | 11.6 |
| Amoxicillin | 56 | 11.5 | 11.6 |
| Azacitidine For | 13 | 10.9 | 10.9 |
| Terbinafine Hydrochloride | 6 | 10.3 | 10.3 |
| Instalax Polyethylene Glycol 3350 | 8 | 9.8 | 9.8 |
| Polyethylene Glycol 400 | 8 | 9.6 | 9.6 |
| Oxazepam | 13 | 9.2 | 9.2 |
| Posaconazole | 9 | 8.4 | 8.4 |
| Azacitidine | 16 | 8.3 | 8.3 |
| Pemetrexed | 10 | 7.1 | 7.1 |
| Abemaciclib | 9 | 6.9 | 6.9 |
| Durvalumab | 8 | 6.0 | 6.0 |